Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Professional Development

An Audience with the Editor of The Times, James Harding

A folded, unmarked newspaper rests on a lectern against a softly rendered auditorium backdrop.

An Audience with the Editor of The Times, James Harding features James Harding, Editor, The Times. This Reuters Institute for the Study of Journalism event takes place on 30 May 2012 at Shulman Auditorium, the Queen’s College, in a Professional Development format.

Hosted with: Psychedelic Writers Guild